JamesNGeorgeMD

Oncology • Oklahoma City, OK

Hematologic Oncology

Professor, Medicine, University of Oklahoma College of Medicine

Join to view full profile

Are you Dr. George?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 45 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
825 NE 10th St
Oupb 5200
Oklahoma City, OK 73104
Phone+1 405-271-8299

Fax+1 405-271-6444

Summary

Dr. James George, MD is an oncologist in Oklahoma City, Oklahoma. He is currently licensed to practice medicine in Oklahoma, Texas, and Ohio. He is affiliated with OU Health, INTEGRIS Deaconess, and OU Medical Center Edmond.

Education & Training

University of RochesterResidency, Internal Medicine, 1966 - 1970
Vanderbilt University Medical CenterResidency, Internal Medicine, 1963 - 1963
Vanderbilt University Medical CenterInternship, Transitional Year, 1962 - 1963
Ohio State University College of MedicineClass of 1962

Certifications & Licensure

OK State Medical License 1990 - 2024
TX State Medical License 1970 - 2006
OH State Medical License 1962 - 1968
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

Elected Member The American Society for Clinical Investigation, 1981

Clinical Trials

Optimal Platelet Dose Strategy for Management of Thrombocytopenia Start of enrollment: 2004 Jul 01
Completed
Phase 3
Safety and Effectiveness of Granulocyte Transfusions in Resolving Infection in People With Neutropenia (The RING Study) Start of enrollment: 2008 Apr 01
Completed
Phase 3
Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP) Start of enrollment: 2009 Apr 01
Terminated
Phase 3
Red Cell Storage Duration Study Start of enrollment: 2010 Jan 01
Completed
Phase 3
Initial Treatment of Patients With Immune Thrombocytopenic Purpura Start of enrollment: 2010 Jan 01
Terminated
Phase 3
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome) Start of enrollment: 2006 Oct 01
Recruiting
Join now to see all

Publications & Presentations

PubMed

1845 citations
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
Francesco Rodeghiero, Roberto Stasi, Terry Gernsheimer, Marc Michel, Drew Provan
Blood. 2009-03-12
283 citations
The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports.
Deirdra R. Terrell, Laura A. Beebe, Sara K. Vesely, Barbara R. Neas, Jodi B Segal
American Journal of Hematology. 2010-03-01
455 citations
Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and ...
Kiarash Kojouri, Sara K. Vesely, Deirdra R. Terrell, James N. George
Blood. 2004-11-01

Grant Support

Oklahoma-Ut Southwestern Hemostasis ConsortiumNational Heart, Lung, And Blood Institute2007–2010
2006 Clinical Research Training InstituteNational Heart, Lung, And Blood Institute2006
Hemostasis ConsortiumNational Heart, Lung, And Blood Institute2002–2006
Clinical Research Training InstituteNational Heart, Lung, And Blood Institute2005
The Role Of Membrane Proteins In Platelet FunctionNational Heart, Lung, And Blood Institute1985